glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Roche obesity drug shows 22.5%

Heres what to keep in mind when it comes to weight loss from Ro: Ro members get access to GLP-1 medications like Wegovy, Zepbound, Foundayo, or Ozempic, if deemed appropriate by a provider

Accumulate over repeated weekly dosing rather than from a single injection

Versatility As a lipolysis solution, you can use Lemon Bottle Fat Dissolving in various areas

Functional improvements generally become noticeable during weeks 2 to 4

Regulatory Frameworks and Supply Dynamics: In December 2025, the FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill, which launched in January 2026, significantly expanding accessibility for patients averse to injections [3]